Literature DB >> 11979245

Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer.

Joseph Romagnuolo1, John Scott, Robert H Hawes, Brenda J Hoffman, Carolyn E Reed, Guruprasad P Aithal, Niall P Breslin, Robert Y M Chen, Bora Gumustop, Winnie Hennessey, Annette Van Velse, Michael B Wallace.   

Abstract

BACKGROUND: Conventional CT is insensitive for detection of metastatic involvement of celiac lymph nodes in esophageal cancer. Helical CT has theoretical advantages over "slice" CT in this regard, but its performance has not yet been prospectively studied.
METHODS: Consecutive patients with untreated esophageal cancer were recruited after obtaining informed consent. Helical CT was performed on all patients and TNM staging was performed by a single radiologist. Subsequently, all patients underwent esophageal radial and, as needed, curvilinear array EUS with fine needle aspiration (FNA), for evaluation of celiac lymph nodes and TNM staging. Test performance characteristics with 95% confidence intervals were calculated, assuming EUS with FNA as the reference standard.
RESULTS: Forty-eight patients were recruited, of whom 37 (77%) were men. The mean (SD) age was 63.6 (10) years. Excluding 5 patients in whom a confirmatory FNA was not available (n = 43), helical CT identified celiac lymph nodes in 12 (28%) patients. The reference standard of EUS with FNA identified 15 (35%) patients with metastatic celiac lymph nodes, giving a sensitivity, specificity, and positive and negative predictive values for helical CT of 53% (95% CI [28%, 79%]), 86% (95% CI [73%, 99%]), 67% (95% CI [40%, 93%]), and 77% (95% CI [63%, 92%]), respectively, for assessing celiac lymph nodal involvement. The sensitivity and specificity of helical CT in detecting T4 disease were 25% (95% CI [3.8%, 46%]) and 94% (95% CI [85%, 100%]), respectively. There were 12 patients (25%; 95% CI [13%, 37%]) who were felt to have resectable disease by helical CT but had either metastatic involvement of celiac lymph nodes or T4 disease by EUS/FNA.
CONCLUSIONS: Despite technological advances, helical CT still appears unreliable, mainly because of insensitivity, for the identification of inoperable T4 or metastatic involvement of celiac lymph node disease in esophageal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 11979245     DOI: 10.1067/mge.2002.122650

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  15 in total

Review 1.  Endoscopic ultrasonography: imaging and beyond.

Authors:  T Rösch
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Contrast enhanced endoscopic ultrasound: More than just a fancy Doppler.

Authors:  Rachid M Mohamed; Brian M Yan
Journal:  World J Gastrointest Endosc       Date:  2010-07-16

3.  Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging.

Authors:  Cherie P Parungo; Shunsuke Ohnishi; Sang-Wook Kim; Sunjee Kim; Rita G Laurence; Edward G Soltesz; Frederick Y Chen; Yolonda L Colson; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

Review 4.  Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: a meta-analysis and systematic review.

Authors:  Srinivas R Puli; Jyotsna B K Reddy; Matthew L Bechtold; Mainor R Antillon; Jamal A Ibdah
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

5.  The role of positron emission tomography in esophageal cancer.

Authors:  Gary Y Yang; Timothy D Wagner; Blair A Jobe; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2008-01

6.  Regional differences in use of endoscopic ultrasonography in Ontario: a population-based retrospective cohort study.

Authors:  Paul D James; Mae Hegagi; Lilia Antonova; Jill Tinmouth; Steven J Heitman; Carmine Simone; Elaine Yeung; Elaine Yong
Journal:  CMAJ Open       Date:  2017-06-07

7.  Low impact of staging EUS for determining surgical resectability in esophageal cancer.

Authors:  M van Zoonen; M G H van Oijen; M S van Leeuwen; R van Hillegersberg; P D Siersema; F P Vleggaar
Journal:  Surg Endosc       Date:  2012-06-13       Impact factor: 4.584

Review 8.  New approach to malignant strictures of the esophagus.

Authors:  Kulwinder S Dua
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 9.  Nonsurgical approaches to esophageal malignancy.

Authors:  Darius Sorbi; David E Fleischer
Journal:  Curr Gastroenterol Rep       Date:  2003-06

10.  Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.

Authors:  Hai-Lin Jin; Hong Zhu; Ting-Sheng Ling; Hong-Jie Zhang; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.